The short version of MC1R fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-12-02. Anything still debated is marked as such rather than presented as settled.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
=== Animal health === In livestock, cattle and sheep commonly show indications when they are copper deficient. Swayback, a sheep disease associated with copper deficiency, imposes enormous costs on farmers worldwide, particularly in Europe, North America, and many tropical countries. For pigs, copper has been shown to be a growth promoter.
=== Fuel === All Buc-ee's travel centers have from 80 to 120 fuel pumps, with gasoline offerings ranging from unleaded (87, 89, 91, and 93 octane, most commonly) to diesel. Some stores include ethanol-free fuel and Diesel exhaust fluid (DEF) as well.
== Discovery == Before the discovery of the ubiquitin–proteasome system, protein degradation in cells was thought to rely mainly on lysosomes, membrane-bound organelles with acidic and protease-filled interiors that can degrade and then recycle exogenous proteins and aged or damaged organelles. However, work by Joseph Etlinger and Alfred L. Goldberg in 1977 on ATP-dependent protein degradation in reticulocytes, which lack lysosomes, suggested the presence of a second intracellular degradation mechanism. This was shown in 1978 to be composed of several distinct protein chains, a novelty among proteases at the time. Later work on modification of histones led to the identification of an unexpected covalent modification of the histone protein by a bond between a lysine side chain of the histone and the C-terminal glycine residue of ubiquitin, a protein that had no known function. It was then discovered that a previously identified protein associated with proteolytic degradation, known as ATP-dependent proteolysis factor 1 (APF-1), was the same protein as ubiquitin. The proteolytic activities of this system were isolated as a multi-protein complex originally called the multi-catalytic proteinase complex by Sherwin Wilk and Marion Orlowski. Later, the ATP-dependent proteolytic complex that was responsible for ubiquitin-dependent protein degradation was discovered and was called the 26S proteasome.
electrophile Any atom or molecule which can accept an electron pair. Most electrophiles carry a net positive charge, include an atom carrying a partial positive charge, or include a neutral atom that does not have a complete octet of electrons, and therefore they attract electron-rich regions of other species; an electrophile with vacant orbitals can accept an electron pair donated by a nucleophile, creating a chemical bond between the two species. Because they accept electrons, electrophiles are Lewis acids by definition.
=== Antibody Drug Conjugates === Antibody drug conjugates (ADCs) are composed of an antibody linked to a drug. Sortase can be used as a method to link these two molecules. Due to the site-specific ligation of sortase, it shows promise in being used as a method to create ADCs. Sortase poses a potential solution to the challenge of creating homogeneous ADCs where the drug is attached to a single specific site. A study showed that sortase derived ADCs can effectively kill tumors both in vitro and in vivo. Using sortase to manufacture ADCs may be able to simplify the production and reduce materials needed for the process. A challenge with using sortase for ADC preparation is the poor reaction kinetics of the natural enzyme. Using error prone PCR to generate mutants of SrtA, the most commonly used natural sortase variant, has been successful in generating more efficient sortase variants.
Sources: en.wikipedia.org
Starting the next row, for potassium and calcium the 4s subshell is the lowest in energy, and therefore it fills next. Potassium adds one electron to the 4s shell ([Ar] 4s1), and calcium then completes it ([Ar] 4s2). However, starting from scandium ([Ar] 3d1 4s2) the 3d subshell becomes the next highest in energy. The 4s and 3d subshells have approximately the same energy and they compete for filling the electrons, and so the occupation is not quite consistently filling the 3d orbitals one at a time. The precise energy ordering of 3d and 4s changes along the row, and also changes depending on how many electrons are removed from the atom. For example, due to the repulsion between the 3d electrons and the 4s ones, at chromium the 4s energy level becomes slightly higher than 3d, and so it becomes more profitable for a chromium atom to have a [Ar] 3d5 4s1 configuration than an [Ar] 3d4 4s2 one. A similar anomaly occurs at copper, whose atom has a [Ar] 3d10 4s1 configuration rather than the expected [Ar] 3d9 4s2. These are violations of the Madelung rule. Such anomalies, however, do not have any chemical significance: most chemistry is not about isolated gaseous atoms, and the various configurations are so close in energy to each other that the presence of a nearby atom can shift the balance. Therefore, the periodic table ignores them and considers only idealized configurations. At zinc ([Ar] 3d10 4s2), the 3d orbitals are completely filled with a total of ten electrons.
==== Hair ==== Hair is considered human remains by some definitions. It is not uncommon within museum collections due to the trend of creating "hairwork", popular during the Victorian era. Locks of hair, hair wreaths, and jewelry made of hair are some of the most commonly found forms.
== Procedure == Two types of clamp are quite commonly used. The hyperglycemic clamp, which requires maintaining a high blood sugar level by perfusion or infusion with glucose, is a way to quantify how fast beta-cells respond to glucose. The hyperinsulinemic clamp, which requires maintaining a high insulin level by perfusion or infusion with insulin, is a way to quantify how sensitive the tissue is to insulin. The hyperinsulinemic clamp is also called euglycemic clamp, meaning a normal blood sugar level is maintained. Hyperglycemic clamp technique: The plasma glucose concentration is acutely raised to 125 mg/dl above basal levels by a continuous infusion of glucose. This hyperglycemic plateau is maintained by adjustment of a variable glucose infusion, based on the rate of insulin secretion and glucose metabolism. Because the plasma glucose concentration is held constant, the glucose infusion rate is an index of insulin secretion and glucose metabolism. The hyperglycemic clamps are often used to assess insulin secretion capacity. Hyperinsulinemic-euglycemic clamp technique: The plasma insulin concentration is acutely raised and maintained at 100 μU/ml by a continuous infusion of insulin. Meanwhile, the plasma glucose concentration is held constant at basal levels by a variable glucose infusion. When the steady-state is achieved, the glucose infusion rate equals glucose uptake by all the tissues in the body and is therefore a measure of tissue insulin sensitivity. The hyperinsulinemic clamps are often used to measure insulin resistance.
It has little arable land and few natural resources, importing most of its food and raw materials. More than 90% of Hong Kong's food is imported, including nearly all of its meat and rice. Agricultural activity is 0.1% of GDP and consists of growing premium food and flower varieties. Although the territory had one of Asia's largest manufacturing economies during the latter half of the colonial era, Hong Kong's economy is now dominated by the service sector. The sector generates 92.7% of economic output, with the public sector accounting for about 10%. Between 1961 and 1997, Hong Kong's gross domestic product increased by a factor of 180, and per capita GDP increased by a factor of 87. The territory's GDP relative to mainland China's peaked at 27% in 1993; it fell to less than 3% in 2017, as the mainland developed and liberalised its economy. Economic and infrastructure integration with China has increased significantly since the 1978 start of the reform and opening up on the mainland. Since resumption of cross-boundary train service in 1979, many rail and road links have been improved and constructed, facilitating trade between regions. The Closer Economic Partnership Arrangement formalised a policy of free trade between the two areas, with each jurisdiction pledging to remove remaining obstacles to trade and cross-boundary investment. A similar economic partnership with Macau details the liberalisation of trade between the special administrative regions. Chinese companies have expanded their economic presence in the territory since the handover.
Sources: en.wikipedia.org
=== Federal government === President: Donald Trump (R-Florida) Vice President: JD Vance (R-Ohio) Chief Justice: John Roberts (Maryland) Speaker of the House of Representatives: Mike Johnson (R-Louisiana) Senate Majority Leader: John Thune (R-South Dakota) Congress: 119th
== External links == Francium at The Periodic Table of Videos (University of Nottingham) WebElements.com – Francium Stony Brook University Physics Dept. Scerri, Eric (2013). A Tale of Seven Elements, Oxford University Press, Oxford, ISBN 9780195391312
== Pharmaceutical variants == The recombinant human G-CSF (rhG-CSF) synthesised in an E. coli expression system is called filgrastim. The structure of filgrastim differs slightly from the structure of the natural glycoprotein. Most published studies have used filgrastim. The Food and Drugs Administration (FDA) first approved filgrastim on February 20, 1991, marketed by Amgen with the brand name Neupogen. It was initially approved to reduce the risk of infection in patients with non-myeloid malignancies who are taking myelosuppressive anti-cancer drugs associated with febrile neutropenia with fever. Several bio-generic versions are now also available in markets such as Europe and Australia. Filgrastim (Neupogen) and PEG-filgrastim (Neulasta), or pegylated form of filgratim, are two commercially available forms of rhG-CSF. The pegylated form of filgratim form has a much longer half-life, reducing the necessity of daily injections. The FDA approved the first biosimilar of Neulasta in June 2018. It is made by Mylan and sold as Fulphila. Another form of rhG-CSF called lenograstim is synthesised in Chinese hamster ovary cells (CHO cells). As this is a mammalian cell expression system, lenograstim is indistinguishable from the 174-amino acid natural human G-CSF. No clinical or therapeutic consequences of the differences between filgrastim and lenograstim have yet been identified, but there are no formal comparative studies.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.